Higashida N, Sakanoue M, Kamada S, Takeuchi M, Shimpo K, Tanabe T
J Toxicol Sci. 1983 Jan;8 Suppl 1:123-39. doi: 10.2131/jts.8.supplementi_123.
A perinatal and postnatal study was carried out in the Crj:CD (SD) rats orally administered ranitidine hydrochloride, a histamine H2-receptor antagonist, at dose levels of 50, 200, and 800 mg/kg/day as base for a period of time from day 17 of gestation to day 21 after delivery. All pregnant rats were allowed to litter naturally, and the postnatal development of the offsprings was observed. In the 800 mg/kg group, the delivery rate was significantly decreased and offspring mortality during the lactation period showed a tendency to increase as compared with control, but the difference was not significant. No significant differences between the control group and the treated groups were found in postnatal growth and differentiation, behavior and reproductive ability of male and female offsprings.
在Crj:CD(SD)大鼠中进行了一项围产期和产后研究,从妊娠第17天至产后第21天,以50、200和800mg/kg/天的剂量水平口服给予组胺H2受体拮抗剂盐酸雷尼替丁一段时间。所有怀孕大鼠均自然产仔,并观察后代的产后发育情况。在800mg/kg组中,与对照组相比,分娩率显著降低,哺乳期后代死亡率有增加的趋势,但差异不显著。在后代的产后生长与分化、行为以及雄性和雌性后代的生殖能力方面,对照组与治疗组之间未发现显著差异。